Analyst Ratings For Prothena (NASDAQ:PRTA)
Today, Deutsche Bank reiterated its Buy rating on Prothena (NASDAQ:PRTA).
Some recent analyst ratings include
- 3/21/2018-Deutsche Bank Reiterated Rating of Buy.
- 3/21/2018-Cantor Fitzgerald Reiterated Rating of Overweight.
- 11/20/2017-Wedbush was Downgraded by analysts at Wedbush from a “Outperform ” rating to a ” Neutral” rating. They now have a $55.00 price target on the stock, up previously from $75.00 .
- 10/2/2017-Jefferies Group Reiterated Rating of Buy.
- 10/2/2017-SunTrust Banks Reiterated Rating of Buy.
- 9/29/2017-Royal Bank of Canada Reiterated Rating of Buy.
- On 10/2/2017 Dennis J Selkoe, Director, sold 3,500 with an average share price of $64.17 per share and the total transaction amounting to $224,595.00.
- On 9/28/2017 Christopher S Henney, Director, sold 900 with an average share price of $70.00 per share and the total transaction amounting to $63,000.00.
- On 9/28/2017 Gene G Kinney, Insider, sold 2,800 with an average share price of $70.00 per share and the total transaction amounting to $196,000.00.
- On 9/27/2017 Tara Nickerson, Insider, sold 4,724 with an average share price of $69.05 per share and the total transaction amounting to $326,192.20.
- On 9/25/2017 Tara Nickerson, Insider, sold 17,500 with an average share price of $63.60 per share and the total transaction amounting to $1,113,000.00.
- On 7/17/2017 Karin L Walker, Insider, sold 5,000 with an average share price of $64.89 per share and the total transaction amounting to $324,450.00.
- On 7/7/2017 Dennis J Selkoe, Director, sold 3,500 with an average share price of $58.11 per share and the total transaction amounting to $203,385.00.
Recent Trading Activity for Prothena (NASDAQ:PRTA)
Shares of Prothena closed the previous trading session at 38.22 up +4.37 12.91% with 2269443 shares trading hands.